跳至主要内容
临床试验/NCT07584603
NCT07584603尚未招募不适用

The Role of High-intensity Laser Therapy on Femoral Cartilage Thickness in Patients With Knee Osteoarthritis

University of Lahore1 个研究点 分布在 1 个国家目标入组 58 人开始时间: 2026年7月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
58
试验地点
1

研究概览

简要总结

This clinical trial will evaluate the effects of High-Intensity Laser Therapy (HILT) on femoral cartilage thickness and other clinical outcomes in people with knee osteoarthritis. Participants aged 40 to 60 years with grade II or III knee osteoarthritis will be randomly assigned to receive either HILT plus conventional physiotherapy or conventional physiotherapy alone. Both groups will receive 12 treatment sessions on alternate days for 4 weeks. The study will assess changes in cartilage thickness using ultrasound, as well as improvements in pain, knee movement, muscle strength, and daily function. Findings from this research may help improve physiotherapy treatment strategies for patients with knee osteoarthritis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

This is a single-blind study. The outcome assessor will be blinded to group allocation, while the participants and treating physiotherapist will be aware of the intervention assigned

入排标准

年龄范围
40 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Male and female participants aged 40-60 years.
  • Diagnosed with knee osteoarthritis (Kellgren-Lawrence grade II or III).
  • Knee pain for at least 3 months.
  • Visual Analogue Scale (VAS) score ≥
  • Willing to provide written informed consent and comply with treatment and follow-up schedule.

排除标准

  • History of knee surgery or traumatic knee injury.
  • Inflammatory arthritis (e.g., gout, psoriatic arthritis).
  • History of cancer or psychiatric illness.
  • Cognitive disorders (e.g., Parkinson's disease, Alzheimer's disease).
  • Severe comorbidities limiting exercise (e.g., severe COPD, heart failure, cerebrovascular event).
  • Hip or ankle joint disability.
  • Intra-articular knee injection within the past 3 months.

研究者

发起方
University of Lahore
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验